Publication: 112

Publication: 112

p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

PubMed

DOI

Google Scholar

Citation:: Urology vol 71 (5) 933-7

Year:: 2008
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 450
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:: CA03927, CA31946, CA32291, CA33601, CA41287, CA60138, CA77406, CA77651

Corr. Author:
Authors:: Anthony V D'Amico Susan Halabi Robin Vollmer Marian Loffredo Elizabeth McMahon Ben Sanford Laura Archer Nicholas J Vogelzang Eric J Small Philip W Kantoff

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-159807, CALGB-9682
Phases:: 2, N/A

Keywords:: Adenocarcinoma, Aged, Aged, 80 and over, Flutamide, Gonadotropin-Releasing Hormone, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Prospective Studies, Prostatic Neoplasms, Risk Factors, Tumor Suppressor Protein p53